Mannkind MNKD
NASDAQ MNKD
$3.80 -0.15 (-3.86%)
As of: Oct 2, 2026 · 9:53 AM EDT

Mannkind (MNKD) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Mannkind (MNKD) recorded Depreciation & Amortization (CF) of $6.4 million in Q2 2026, up 206.6% from $2.09 million a year earlier and up 0.3% from the prior quarter.

Analysis

Mannkind (MNKD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Mannkind's Depreciation & Amortization (CF) came in at $20.87 million as of Jun 30, 2026, up 146.4% year-over-year; for FY2025, it came in at $12.28 million, up 66.7% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for four straight years, with a five-year compound annual growth rate of 41.7% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $7.37 million in FY2024 (+62.5%), $4.54 million in FY2023 (+36.4%), $3.33 million in FY2022 (+67.4%) and $1.99 million in FY2021 (-7.6%).
  • The Q2 2026 figure is the highest quarterly Depreciation & Amortization (CF) since Q1 2014.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for three consecutive quarters, with growth averaging 105.3% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 206.6% in Q2 2026, against a decline of 28.4% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.38 million (Q1 2026), $6.03 million (Q4 2025) and $2.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Mannkind 1.21 Bn 529.30 Mn 94.97 Mn 6.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.40 Mn
Mar 31, 2026 6.38 Mn
Dec 31, 2025 6.03 Mn
Sep 30, 2025 2.06 Mn
Jun 30, 2025 2.09 Mn
Mar 31, 2025 2.11 Mn
Dec 31, 2024 2.16 Mn
Sep 30, 2024 2.12 Mn
Jun 30, 2024 1.73 Mn
Mar 31, 2024 1.36 Mn
Dec 31, 2023 1.23 Mn
Sep 30, 2023 1.03 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.06 Mn
Dec 31, 2022 1.02 Mn
Sep 30, 2022 982,000.00
Jun 30, 2022 727,000.00
Mar 31, 2022 599,000.00
Dec 31, 2021 -1.01 Mn
Sep 30, 2021 1.32 Mn
API Access

Mannkind Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MNKD&period=max&api_key=YOUR_API_KEY